These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16801671)

  • 1. Distinguishing early-onset PD from dopa-responsive dystonia with transcranial sonography.
    Hagenah JM; Hedrich K; Becker B; Pramstaller PP; Seidel G; Klein C
    Neurology; 2006 Jun; 66(12):1951-2. PubMed ID: 16801671
    [No Abstract]   [Full Text] [Related]  

  • 2. Early-onset parkinsonism with dystonia. Clinical and biochemical differences from hereditary progressive dystonia or DOPA-responsive dystonia.
    Furukawa Y; Mizuno Y; Narabayashi H
    Adv Neurol; 1996; 69():327-37. PubMed ID: 8615147
    [No Abstract]   [Full Text] [Related]  

  • 3. Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism.
    Snow BJ; Nygaard TG; Takahashi H; Calne DB
    Ann Neurol; 1993 Nov; 34(5):733-8. PubMed ID: 8239569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa-responsive dystonia.
    Nygaard TG; Takahashi H; Heiman GA; Snow BJ; Fahn S; Calne DB
    Ann Neurol; 1992 Nov; 32(5):603-8. PubMed ID: 1449240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical heterogeneity of dopa-responsive dystonia: PET observations.
    Takahashi H; Snow BJ; Nygaard TG; Calne DB
    Adv Neurol; 1993; 60():586-90. PubMed ID: 8420195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopa-responsive, nonprogressive juvenile parkinsonism: report of a case.
    Rajput A; Kishore A; Snow B; Bolton CF; Rajput AH
    Mov Disord; 1997 May; 12(3):453-6. PubMed ID: 9159748
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopa responsive dystonia and juvenile Parkinson's disease: two subtypes of the same disorder?
    Lamberti P; de Mari M; Iliceto G; Federico F
    Acta Neurol (Napoli); 1992; 14(4-6):451-4. PubMed ID: 1293988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical Gait Response to Levodopa in Parkin-Gene-Related Early-Onset Parkinson's Disease: Dopa Worsening Dystonia.
    Mehta A; Naheed D; Tan LCS; Neo S
    Mov Disord Clin Pract; 2024 May; 11(5):580-581. PubMed ID: 38497514
    [No Abstract]   [Full Text] [Related]  

  • 9. Striatal dopamine D2 receptor alterations and response to L-DOPA in Parkinson's disease. A [123I]IBZM SPET study.
    Pizzolato G; Cagnin A; Rossato A; Chierichetti F; Fabbri M; Dam M; Ferlin G; Battistin L
    Adv Neurol; 1996; 69():467-73. PubMed ID: 8615167
    [No Abstract]   [Full Text] [Related]  

  • 10. Dopa-responsive dystonia. Delineation of the clinical syndrome and clues to pathogenesis.
    Nygaard TG
    Adv Neurol; 1993; 60():577-85. PubMed ID: 8420194
    [No Abstract]   [Full Text] [Related]  

  • 11. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease.
    Walter U; Dressler D; Probst T; Wolters A; Abu-Mugheisib M; Wittstock M; Benecke R
    Arch Neurol; 2007 Nov; 64(11):1635-40. PubMed ID: 17998447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term L-DOPA therapy: challenges to our understanding and for the care of people with Parkinson's disease.
    Nutt JG
    Exp Neurol; 2003 Nov; 184(1):9-13. PubMed ID: 14637071
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dopa-therapy in the treatment of early stage Parkinson's disease].
    Broussolle E
    Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():91-7. PubMed ID: 10916042
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
    Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
    Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinguishing Parkinson's disease and essential tremor with transcranial sonography.
    Budisic M; Trkanjec Z; Bosnjak J; Lovrencic-Huzjan A; Vukovic V; Demarin V
    Acta Neurol Scand; 2009 Jan; 119(1):17-21. PubMed ID: 18549415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A family with hereditary juvenile dystonia-parkinsonism.
    Ishikawa A; Miyatake T
    Mov Disord; 1995 Jul; 10(4):482-8. PubMed ID: 7565830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET scan study on the dopaminergic system in a Japanese patient with hereditary progressive dystonia (Segawa's disease). Case report.
    Okada A; Nakamura K; Snow BJ; Bhatt MH; Nomoto M; Osame M; Calne DB
    Adv Neurol; 1993; 60():591-4. PubMed ID: 8420196
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential effects of levodopa on dopaminergic function in early and advanced Parkinson's disease.
    Torstenson R; Hartvig P; Långström B; Westerberg G; Tedroff J
    Ann Neurol; 1997 Mar; 41(3):334-40. PubMed ID: 9066354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is transcranial sonography useful to distinguish drug-induced parkinsonism from Parkinson's disease?
    Mahlknecht P; Stockner H; Kiechl S; Willeit J; Rastner V; Gasperi A; Rungger G; Poewe W; Seppi K
    Mov Disord; 2012 Aug; 27(9):1194-6. PubMed ID: 22692761
    [No Abstract]   [Full Text] [Related]  

  • 20. Brain biopterin and tyrosine hydroxylase in asymptomatic dopa-responsive dystonia.
    Furukawa Y; Kapatos G; Haycock JW; Worsley J; Wong H; Kish SJ; Nygaard TG
    Ann Neurol; 2002 May; 51(5):637-41. PubMed ID: 12112113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.